Evidence map›Paper›PMID 41419615›Full record

ArticleMikrochimica acta2025

Novel dual type-II WO

Yanrui Xu, Hongfen Zhang, Zilong Zhang, Jie Li, Feifei Zong, Yurui Qi, Yaru Wang, Yadan Wu

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yanrui XuSchool of Pharmacy, Shanxi Medical University, Jinzhong, 030619, Shanxi, China.
Hongfen ZhangSchool of Pharmacy, Shanxi Medical University, Jinzhong, 030619, Shanxi, China. zhanghf_2007@126.com.
Zilong ZhangSchool of Pharmacy, Shanxi Medical University, Jinzhong, 030619, Shanxi, China.
Jie LiSchool of Pharmacy, Shanxi Medical University, Jinzhong, 030619, Shanxi, China.
Feifei ZongSchool of Pharmacy, Shanxi Medical University, Jinzhong, 030619, Shanxi, China.
Yurui QiSchool of Pharmacy, Shanxi Medical University, Jinzhong, 030619, Shanxi, China.
Yaru WangSchool of Pharmacy, Shanxi Medical University, Jinzhong, 030619, Shanxi, China.
Yadan WuSchool of Pharmacy, Shanxi Medical University, Jinzhong, 030619, Shanxi, China.

Funding

Shanxi Province Higher Education "Billion Project" Science and Technology Guidance Project IDD/SXMU-2024-01
6 · The paper itself

Abstract

Given the extreme toxicity and carcinogenicity of aflatoxin B1 (AFB1) in foodstuffs and medicinal products, ultrasensitive detection for it is critically important. Herein, we engineered a type-II dual WO

Indexed as

Aflatoxin B1Aptamers, NucleotideBiosensing TechniquesElectrochemical TechniquesCopperFood ContaminationGoldGraphiteLimit of DetectionMetal NanoparticlesNitrogen CompoundsOxidesPhotochemical ProcessesTungstenAflatoxin B1Aptamers, NucleotideCopperGoldGraphitegraphitic carbon nitrideNitrogen CompoundsOxidesTungstentungsten oxideAflatoxin B1Dual type-ⅠⅠ heterojunctionHighly sensitive detectionPEC aptasensor

Identifiers

PMID41419615

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.